CSPC Pharmaceutical Group Limited (CVG) - Total Liabilities

Latest as of December 2025: €12.15 Billion EUR ≈ $14.20 Billion USD

Based on the latest financial reports, CSPC Pharmaceutical Group Limited (CVG) has total liabilities worth €12.15 Billion EUR (≈ $14.20 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore CVG long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

CSPC Pharmaceutical Group Limited - Total Liabilities Trend (2013–2025)

This chart illustrates how CSPC Pharmaceutical Group Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see CVG current and non-current assets.

CSPC Pharmaceutical Group Limited Competitors by Total Liabilities

The table below lists competitors of CSPC Pharmaceutical Group Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Deutsche Lufthansa AG F:LHAB	Germany	€36.68 Billion
Sartorius Aktiengesellschaft XETRA:SRT3	Germany	€5.60 Billion
Antero Midstream Partners LP NYSE:AM	USA	$4.42 Billion
The Clorox Company NYSE:CLX	USA	$6.34 Billion
Gongniu Group Co Ltd SHG:603195	China	CN¥6.23 Billion
Boston Properties Inc NYSE:BXP	USA	$17.38 Billion
Modine Manufacturing Company NYSE:MOD	USA	$1.59 Billion
Banque Cantonale Vaudoise SW:BCVN	Switzerland	CHF57.64 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down CSPC Pharmaceutical Group Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See CSPC Pharmaceutical Group Limited (CVG) net asset quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.19	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.37	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how CSPC Pharmaceutical Group Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for CSPC Pharmaceutical Group Limited (2013–2025)

The table below shows the annual total liabilities of CSPC Pharmaceutical Group Limited from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	€12.15 Billion ≈ $14.20 Billion	+15.44%
2024-12-31	€10.52 Billion ≈ $12.30 Billion	-6.58%
2023-12-31	€11.26 Billion ≈ $13.17 Billion	+11.22%
2022-12-31	€10.13 Billion ≈ $11.84 Billion	+27.99%
2021-12-31	€7.91 Billion ≈ $9.25 Billion	+13.55%
2020-12-31	€6.97 Billion ≈ $8.15 Billion	+2.48%
2019-12-31	€6.80 Billion ≈ $7.95 Billion	-11.36%
2018-12-31	€7.67 Billion ≈ $8.97 Billion	+49.65%
2017-12-31	€5.13 Billion ≈ $5.99 Billion	+25.32%
2016-12-31	€4.09 Billion ≈ $4.78 Billion	-13.46%
2015-12-31	€4.73 Billion ≈ $5.53 Billion	+8.68%
2014-12-31	€4.35 Billion ≈ $5.09 Billion	-5.52%
2013-12-31	€4.60 Billion ≈ $5.38 Billion	--

About CSPC Pharmaceutical Group Limited

F:CVG Germany Drug Manufacturers - General

Market Cap

$13.07 Billion

€11.18 Billion EUR

Market Cap Rank

#2235 Global

#465 in Germany

Share Price

€0.98

Change (1 day)

+1.71%

52-Week Range

€0.73 - €1.13

All Time High

€1.25